Laboratory Safety & Biosafety Training Development and Delivery

The contract involves the design, development, and delivery of laboratory safety and biosafety training programs specifically tailored for FDA personnel. These training sessions will be provided in both virtual and in-person formats to accommodate diverse learning preferences and operational needs. The effort focuses on ensuring that FDA staff are adequately educated and equipped to maintain high standards of safety in laboratory environments. This subcontract, categorized under NAICS code 611430, is issued by the FDA Office of Acquisition and Grant Services, part of the Department of Health and Human Services. The performance location for the contract is Silver Spring. The solicitation was posted on May 19, 2026, with a response deadline of June 9, 2026. The contract aims to enhance the FDA’s internal training capabilities by delivering comprehensive and accessible safety education aligned with regulatory and institutional requirements.